Innovita Biological Technology Co LtdSHG 688253 Stock Report

Innovita Biological Technology Co Ltd is a CN-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Beijing, Beijing and currently employs 386 full-time employees. The company went IPO on 2022-07-28. Innovita Biological Technology Co Ltd is a China-based company mainly engaged in the research, development, production and sales of point-of-care testing (POCT) rapid diagnostic products. The firm's main products include novel coronavirus (2019-nCoV) neutralizing antibody detection kits using colloidal gold, quantum dot fluorescence immunochromatography and chemiluminescence techniques, and respiratory pathogen detection products, such as whole blood respiratory quintuple detection card, influenza virus triple detection card, virus serum quintuple detection card, respiratory pathogen nine indirect immunofluorescence kit, and others.